Development and validation of prognostic nomogram for elderly patients with clear cell renal cell carcinoma based on the SEER database

被引:1
作者
Lin, Mingxin [1 ]
Wang, Cong [1 ]
Zhou, Jianan [1 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China
关键词
elderly clear cell renal cell carcinoma; nomogram; overall survival; SEER; PREDICTING RECURRENCE; CLASSIFICATION; SURVIVAL; DISEASE;
D O I
10.1097/MD.0000000000035694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study sought to establish nomogram models of overall survival (OS) in patients with elderly clear cell renal cell carcinoma (ECCRCC). The Surveillance, Epidemiology, and End Results database provided data of the ECCRCC-afflicted patients diagnosed during the period from 2010 to 2015. This data was subsequently segregated into the training and validation sets randomly in a 7:3 ratio. The calibration curves, the receiver operating characteristic curves, the decision curve analysis and the Concordance index (C-index) were applied for the model evaluation. 9201 eligible cases from 2010 to 2015 were extracted; 6441 were included in the training cohort and 2760 in the validation cohort. The C-index for the training and validation sets were 0.710 and 0.709, respectively. The receiver operating characteristic and decision curve analysis curves demonstrated that nomograms outperformed the AJCC stage in predictive performance. Moreover, the nomogram was found to match closely with the actual observation, as indicated by the calibration plots. To make predictions with regard to the survival of the ECCRCC-afflicted individuals, and as a guide for treatment, the new nomogram could be used.
引用
收藏
页数:8
相关论文
共 31 条
  • [1] Nomograms in oncology: more than meets the eye
    Balachandran, Vinod P.
    Gonen, Mithat
    Smith, J. Joshua
    DeMatteo, Ronald P.
    [J]. LANCET ONCOLOGY, 2015, 16 (04) : E173 - E180
  • [2] Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
    Bian, Zichen
    Meng, Jialin
    Niu, Qingsong
    Jin, Xiaoyan
    Wang, Jinian
    Feng, Xingliang
    Che, Hong
    Zhou, Jun
    Zhang, Li
    Zhang, Meng
    Liang, Chaozhao
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8481 - 8490
  • [3] Epidemiology of Renal Cell Carcinoma: 2022 Update
    Bukavina, Laura
    Bensalah, Karim
    Bray, Freddie
    Carlo, Maria
    Challacombe, Ben
    Karam, Jose A.
    Kassouf, Wassim
    Mitchell, Thomas
    Montironi, Rodolfo
    O'Brien, Tim
    Panebianco, Valeria
    Scelo, Ghislaine
    Shuch, Brian
    van Poppel, Hein
    Blosser, Christopher D.
    Psutka, Sarah P.
    [J]. EUROPEAN UROLOGY, 2022, 82 (05) : 529 - 542
  • [4] Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer
    Dong, Shengtao
    Yang, Hua
    Tang, Zhi-Ri
    Ke, Yuqi
    Wang, Haosheng
    Li, Wenle
    Tian, Kang
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Markers of local kidney cancer recurrence: A surgeon's mistake or a pattern? Review
    Gaas, Margarita Y.
    Kaprin, Andrey D.
    Vorobyev, Nikolay V.
    Rapoport, Leonid M.
    Korolev, Dmitry O.
    Kalpinsky, Alexey S.
    [J]. UROLOGIA JOURNAL, 2023, 90 (03) : 459 - 469
  • [6] Gettman MT, 2001, CANCER, V91, P354, DOI 10.1002/1097-0142(20010115)91:2<354::AID-CNCR1009>3.0.CO
  • [7] 2-9
  • [8] Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis
    Gong, Dongkui
    Sun, Yin
    Guo, Changcheng
    Sheu, Tzong-jen
    Zhai, Wei
    Zheng, Junhua
    Chang, Chawnshang
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [9] Renal Cancer in the Elderly
    Gonzalez Leon, Tania
    Morera Perez, Maricela
    [J]. CURRENT UROLOGY REPORTS, 2016, 17 (01) : 1 - 9
  • [10] Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8